Bayer Czech Republic made a net profit of CZK 123 mil under revenues of CZK 4,277 mil in 2015, up 15.4% and 5.49%, respectively, when compared to the last year. This translates into a net margin of 2.89%.
Historically, the firm’s net profit reached an all time high of CZK 166 mil in 2011 and an all time low of CZK -11.8 mil in 2007. Since 2010, the firm's net profit has increased 3.79% or 0.746% a year on average.
On the operating level, EBITDA reached CZK 168 mil, up 17.5% when compared to the previous year. Over the last five years, company's EBITDA has grown -0.038% a year on average.
As far as Bayer Czech Republic's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 0.936% and 3.84%, respectively in 2015 and Amgen Czech Republic generated margins of 5.93% and 7.66%.